The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells

Translational Oncology

Volumn 10, Issue 4, 2017, Pages 555-569

  Balça Silva, Joana ^a,b,c   Matias, Diana ^c,d   Dubois, Luiz Gustavo ^c   Carneiro, Brenno ^d   do Carmo, Anália ^a,e   Girão, Henrique ^a,b   Ferreira, Fernanda ^d   Ferrer, Valeria Pereira ^c   Chimelli, Leila ^c   Filho, Paulo Niemeyer ^c   Tão, Hermínio ^f   Rebelo, Olinda ^f   Barbosa, Marcos ^b,f   Sarmento Ribeiro, Ana Bela ^a,b,f   Lopes, Maria Celeste ^a,g   Moura Neto, Vivaldo ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Neuroendocrine Section   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; CONNEXIN 46; GAP JUNCTION PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL COMMUNICATION; CELL PLASTICITY; CLONOGENIC ASSAY; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 85026894919     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1016/j.tranon.2017.04.005     Document Type: Article

References (50)

1. Louis, DN, Perry, A, Reifenberger, G, von Deimling, A, Figarella-Branger, D, Cavenee, WK, Ohgaki, H, Wiestler, OD, Kleihues, P, Ellison, DW, The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol, 2016, 1–18, 10.1007/s00401-016-1545-1.
2. Singh, SK, Hawkins, C, Clarke, ID, Squire, JA, Bayani, J, Hide, T, Henkelman, RM, Cusimano, MD, Dirks, PB, Identification of human brain tumour initiating cells. Nature 432 (2004), 396–401, 10.1038/nature03128.
3. Oliveira-Nunes, MC, Assad Kahn, S, de Oliveira Barbeitas, AL, Spohr, TCL de SE, Dubois, LGF, Ventura Matioszek, GM, Querido, W, Campanati, L, de Brito Neto, JM, Lima, FRS, et al. The availability of the embryonic TGF-β protein Nodal is dynamically regulated during glioblastoma multiforme tumorigenesis. Cancer Cell Int, 16, 2016, 46, 10.1186/s12935-016-0324-3.
4. Stupp, R, Mason, WP, van den Bent, MJ, Weller, M, Fisher, B, Taphoorn, MJB, Belanger, K, Brandes, AA, Marosi, C, Bogdahn, U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005), 987–996, 10.1056/NEJMoa043330.
5. Deheeger, M, Lesniak, MS, Ahmed, AU, Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance. Cancer Cell Microenviron, 1, 2014, 10.14800/ccm.295.
6. Huse, JT, Holland, E, DeAngelis, LM, Glioblastoma: molecular analysis and clinical implications. Annu Rev Med 64 (2013), 59–70, 10.1146/annurev-med-100711-143028.
7. Grossman, SA, Ye, X, Piantadosi, S, Desideri, S, Nabors, LB, Rosenfeld, M, Fisher, J, NABTT CNS Consortium, Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 16 (2010), 2443–2449, 10.1158/1078–0432.CCR-09-3106.
8. Singh, SK, Hawkins, C, Clarke, ID, Squire, JA, Bayani, J, Hide, T, Henkelman, RM, Cusimano, MD, Dirks, PB, Identification of human brain tumour initiating cells. Nature 432 (2004), 396–401, 10.1038/nature03031.1.
9. Ding, L, Ley, TJ, Larson, DE, Miller, CA, Koboldt, DC, Welch, JS, Ritchey, JK, Young, MA, Lamprecht, T, McLellan, MD, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481 (2012), 506–510, 10.1038/nature10738.
10. Schuh, A, Becq, J, Humphray, S, Alexa, A, Burns, A, Clifford, R, Feller, SM, Grocock, R, Henderson, S, Khrebtukova, I, et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 120 (2012), 4191–4196, 10.1182/blood-2012-05-433540.
11. Shah, SP, Roth, A, Goya, R, Oloumi, A, Ha, G, Zhao, Y, Turashvili, G, Ding, J, Tse, K, Haffari, G, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486 (2012), 395–399, 10.1038/nature10933.
12. Nik-Zainal, S, Van Loo, P, Wedge, DC, Alexandrov, LB, Greenman, CD, Lau, KW, Raine, K, Jones, D, Marshall, J, Ramakrishna, M, et al. The life history of 21 breast cancers. Cell 149 (2012), 994–1007, 10.1016/j.cell.2012.04.023.
13. Garcia, C, Dubois, L, Xavier, A, Geraldo, L, da Fonseca, AC, Correia, A, Meirelles, F, Ventura, G, Romão, L, Canedo, NH, et al. The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model. BMC Cancer, 14, 2014, 923, 10.1186/1471-2407-14-923.
14. Seymour, T, Nowak, A, Kakulas, F, Targeting aggressive cancer stem cells in glioblastoma. Front Oncol, 5, 2015, 159, 10.3389/fonc.2015.00159.
15. Todorova, MG, Soria, B, Quesada, I, Gap junctional intercellular communication is required to maintain embryonic stem cells in a non-differentiated and proliferative state. J Cell Physiol 214 (2008), 354–362, 10.1002/jcp.21203.
16. Naus, CC, Laird, DW, Implications and challenges of connexin connections to cancer. Nat Rev Cancer 10 (2010), 435–441, 10.1038/nrc2841.
17. Evans, W.H., Martin, P.E.M., Gap junctions: structure and function. Mol Membr Biol 19 (2002), 121–136, 10.1080/09687680210139839 [Review].
18. Saez, JC, Berthoud, VM, Branes, MC, Martinez, AD, Beyer, EC, Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83 (2003), 1359–1400, 10.1152/physrev.00007.2003.
19. Orellana, JA, von Bernhardi, R, Giaume, C, Sáez, JC, Glial hemichannels and their involvement in aging and neurodegenerative diseases. Rev Neurosci 23 (2012), 163–177, 10.1515/revneuro-2011-0065.
20. Soares, AR, Martins-Marques, T, Ribeiro-Rodrigues, T, Ferreira, JV, Catarino, S, Pinho, MJ, Zuzarte, M, Isabel Anjo, S, Manadas, B, Sluijter, JPG, et al. Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells. Sci Rep, 5, 2015, 13243, 10.1038/srep13243.
21. Hitomi, M, Deleyrolle, LP, Mulkearns-Hubert, EE, Jarrar, A, Li, M, Sinyuk, M, Otvos, B, Brunet, S, Flavahan, WA, Hubert, CG, et al. Differential connexin function enhances self-renewal in glioblastoma. Cell Rep 11 (2015), 1031–1042, 10.1016/j.celrep.2015.04.021.
22. Liu, Y, Lu, W, Recent advances in brain tumor-targeted nano-drug delivery systems. Expert Opin Drug Deliv 9 (2012), 671–686, 10.1517/17425247.2012.682726.
23. Safa, AR, Saadatzadeh, MR, Cohen-Gadol, AA, Pollok, KE, Bijangi-Vishehsaraei, K, Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Dis 2 (2015), 152–163, 10.1016/j.gendis.2015.02.001.
24. Tata, PR, Mou, H, Pardo-Saganta, A, Zhao, R, Prabhu, M, Law, BM, Vinarsky, V, Cho, JL, Breton, S, Sahay, A, et al. Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature 503 (2013), 218–223, 10.1038/nature12777.
25. Chaffer, CL, Brueckmann, I, Scheel, C, Kaestli, AJ, Wiggins, PA, Rodrigues, LO, Brooks, M, Reinhardt, F, Su, Y, Polyak, K, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 108 (2011), 7950–7955, 10.1073/pnas.1102454108.
26. Meacham, CE, Morrison, SJ, Tumour heterogeneity and cancer cell plasticity. Nature 501 (2013), 328–337, 10.1038/nature12624.
27. Easwaran, H, Tsai, H-C, Baylin, SB, Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 54 (2014), 716–727, 10.1016/j.molcel.2014.05.015.
28. Kahn, SA, Biasoli, D, Garcia, C, Geraldo, LH, Pontes, B, Sobrinho, M, Frauches, AC, Romao, L, Soletti, RC, Assuncao Fdos, S, et al. Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death. Curr Top Med Chem 12 (2012), 2082–2093 http://www.ncbi.nlm.nih.gov/pubmed/23167797.
29. Faria, J, Romão, L, Martins, S, Alves, T, Mendes, FA, De Faria, GP, Hollanda, R, Takiya, C, Chimelli, L, Morandi, V, et al. Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Differentiation 74 (2006), 562–572, 10.1111/j.1432–0436.2006.00090.x.
30. Patru, C, Romao, L, Varlet, P, Coulombel, L, Raponi, E, Cadusseau, J, Renault-Mihara, F, Thirant, C, Leonard, N, Berhneim, A, et al. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer, 10, 2010, 66, 10.1186/1471-2407-10-66.
31. Thirant, C, Bessette, B, Varlet, P, Puget, S, Cadusseau, J, Tavares, SDR, Studler, J-M, Silvestre, DC, Susini, A, Villa, C, et al. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors. PLoS One, 6, 2011, e16375, 10.1371/journal.pone.0016375.
32. Towbin, H, Staehelin, T, Gordon, J, Immunoblotting in the clinical laboratory. J Clin Chem Clin Biochem 27 (1989), 495–501 [http://www.ncbi.nlm.nih.gov/pubmed/2681521 accessed October 18, 2016].
33. Balça-Silva, J, Matias, D, Do Carmo, A, Girão, H, Moura-Neto, V, Sarmento-Ribeiro, AB, Lopes, MC, Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines. Biochim Biophys Acta 1850 (2015), 722–732, 10.1016/j.bbagen.2014.12.022.
34. Pfaffl, MW, A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29, 2001, e45 [http://www.ncbi.nlm.nih.gov/pubmed/11328886 accessed April 14, 2017].
35. Reference, JE, Bottenstein, product info_N2-K. 1985.
36. Brewer, GJ, Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 42 (1995), 674–683, 10.1002/jnr.490420510.
37. Tam, WL, Weinberg, RA, The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 19 (2013), 1438–1449, 10.1038/nm.3336.
38. Tania, M, Khan, MA, Fu, J, Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumour Biol 35 (2014), 7335–7342, 10.1007/s13277-014-2163-y.
39. Mallini, P, Lennard, T, Kirby, J, Meeson, A, Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev 40 (2014), 341–348, 10.1016/j.ctrv.2013.09.008.
40. Soroceanu, L, Manning, TJ, Sontheimer, H, Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 33 (2001), 107–117 [http://www.ncbi.nlm.nih.gov/pubmed/11180508 accessed October 18, 2016].
41. Lima, FRS, Kahn, SA, Soletti, RC, Biasoli, D, Alves, T, da Fonseca, ACC, Garcia, C, Romão, L, Brito, J, Holanda-Afonso, R, et al. Glioblastoma: therapeutic challenges, what lies ahead. Biochim Biophys Acta 1826 (2012), 338–349, 10.1016/j.bbcan.2012.05.004.
42. Dubois, LG, Campanati, L, Righy, C, D'Andrea-Meira, I, Spohr, TCL de SE, Porto-Carreiro, I, Pereira, CM, Balça-Silva, J, Kahn, SA, DosSantos, MF, et al. Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci, 8, 2014, 418, 10.3389/fncel.2014.00418.
43. Stupp, R, Hegi, ME, Mason, WP, van den Bent, MJ, Taphoorn, MJB, Janzer, RC, Ludwin, SK, Allgeier, A, Fisher, B, Belanger, K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10 (2009), 459–466, 10.1016/S1470–2045(09)70025-7.
44. Diaz, A, Leon, K, Therapeutic approaches to target cancer stem cells. Cancers (Basel) 3 (2011), 3331–3352, 10.3390/cancers3033331.
45. Ortensi, B, Setti, M, Osti, D, Pelicci, G, Cancer stem cell contribution to glioblastoma invasiveness. Stem Cell Res Ther, 4, 2013, 18, 10.1186/scrt166.
46. Visvader, JE, Lindeman, GJ, Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10 (2012), 717–728, 10.1016/j.stem.2012.05.007.
47. Wei, C-J, Xu, X, Lo, CW, Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol 20 (2004), 811–838, 10.1146/annurev.cellbio.19.111301.144309.
48. Würth, R, Barbieri, F, Florio, T, New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells. Biomed Res Int, 2014, 2014, 126586, 10.1155/2014/126586.
49. Jackson, M, Hassiotou, F, Nowak, A, Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target. Carcinogenesis 36 (2015), 177–185, 10.1093/carcin/bgu243.
50. Altaner, C, Altanerova, V, Stem cell based glioblastoma gene therapy. Neoplasma 59 (2012), 756–760, 10.4149/neo_2012_95.